Log In
Print
BCIQ
Print
Print this Print this
 

ProCervix

  Manage Alerts
Collapse Summary General Information
Company Genticel S.A.
DescriptionBivalent therapeutic cancer vaccine against HPV types 16 and 18
Molecular Target Human papillomavirus (HPV) antigens
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today